Burfiralimab (hzVSF-v13) is a monoclonal antibody directed against waveform proteins expressed on the surface of virus-infected cells with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation.
CAS Number:
[2460809-80-5]
* VAT and and shipping costs not included. Errors and price changes excepted